Wall Street Analysts See a 152.53% Upside in Voyager Therapeutics (VYGR): Can the Stock Really Move This High?

Shares of Voyager Therapeutics (VYGR) have gained 4.2% over the past four weeks to close the last trading session at $6.93, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $17.50 indicates a potential upside of 152.5%.The average comprises 10 short-term price targets ranging from a low of $11 to a high of $30, with a standard deviation of $5.36. While the lowest estimate indicat ...